By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


XBiotech USA, Inc. 

8201 E Riverside Drive
Building 4, Suite 100
Austin  Texas  78744  U.S.A.
Phone: 512-386-5107 Fax: n/a


Start Up

Company News
Austin Biotech Firm XBiotech USA, Inc. Begins Construction On $200 Million Campus 9/25/2014 7:32:18 AM
XBiotech USA, Inc. Halts Cancer Study On Positive Phase 3 Results 9/2/2014 1:11:00 PM
XBiotech USA, Inc. Enrolls First Patient In Phase III European Registration Study Using Xilonix™ For Treatment Of Colorectal Cancer 8/4/2014 6:37:40 AM
XBiotech USA, Inc. Announces Phase I/II Study Results In Lancet 4/17/2014 12:26:11 PM
XBiotech USA, Inc. Welcomes Addition Of Senior Vice President Corporate Development & General Counsel 4/16/2014 6:24:48 AM
XBiotech USA, Inc. Issued Patent For Antibody Therapy To Treat Chronic Sterile Inflammatory Diseases 3/12/2014 10:24:09 AM
XBiotech USA, Inc. And European Medicines Agency Agree On Phase III Registration Study For Treatment Of Colorectal Cancer 1/30/2014 10:24:22 AM
XBiotech USA, Inc. Announces Launch Of Study To Treat Pyoderma Gangrenosum (PG) 1/17/2014 8:04:00 AM
XBiotech USA, Inc. Announces Addition to its Board of Directors 8/30/2013 6:24:47 AM
XBiotech USA, Inc. Announces Results for Its XILONIX™ Treatment of Non-Small Cell Lung Cancer (NSCLC) 5/16/2013 9:48:38 AM